Davis Todd C

CIK 00013920295 companiesLA JOLLA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001392029

Recent Transactions

50 trades

Gift
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-12-04−130→ 161,337 total
Award
Pelthos Therapeutics Inc.$PTHS
Stock Option
2025-07-02+58,230→ 58,230 total
Award
Pelthos Therapeutics Inc.$PTHS
Restricted Stock Units
2025-07-02+19,108→ 36,969 total
Conversion
Pelthos Therapeutics Inc.$PTHS
Common Stock
2025-07-01$10.00/sh+1,500,000→ 1,500,000 total
Conversion
Pelthos Therapeutics Inc.$PTHS
Series A Convertible Preferred Stock
2025-07-01−15,000→ 3,000 total
Other
Pelthos Therapeutics Inc.$PTHS
Series A Convertible Preferred Stock
2025-07-01+31,278.681→ 3,127,868 total
Other
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-06-30$91.08/sh+233→ 161,467 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Non-Qualified Stock Option (right to buy)
2025-06-10+12,350→ 12,350 total
Purchase
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-05-09$104.53/sh+2,307→ 155,711 total
Purchase
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-05-09$105.67/sh+5,523→ 161,234 total
Purchase
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-05-09$104.57/sh+1,680→ 153,404 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-03-04+21,382→ 151,724 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2025-03-04+93,476→ 93,476 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-02-15$120.00/sh−2,231→ 134,597 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-02-15$120.00/sh−4,255→ 130,342 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-02-14+20,784→ 143,794 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-02-14$120.00/sh−6,966→ 136,828 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Stock Option (right to buy)
2024-12-13+24,700→ 24,700 total
Purchase
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-08-08$97.39/sh+2,500→ 123,010 total
Other
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-06-28$60.71/sh+350→ 120,510 total
Award
Pelthos Therapeutics Inc.$PTHS
Restricted Stock Units
2024-06-14+128,977→ 213,701 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2024-03-25−2,156→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-03-25$68.51/sh+2,156→ 116,604 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2024-03-25−2,855→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2024-03-25−3,556→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2024-03-25−7,448→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-03-25$66.19/sh+3,556→ 120,160 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-03-25$67.24/sh+2,855→ 114,448 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-03-25$46.20/sh+7,448→ 111,593 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2024-02-27+131,723→ 131,723 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-02-27+32,436→ 104,145 total
Conversion
Pelthos Therapeutics Inc.$PTHS
Secured Convertible Promissory Note
2024-02-21→ 0 total
Exercise/Conversion
Pelthos Therapeutics Inc.$PTHS
Common Stock
2024-02-21$4.80/sh+29,167→ 29,167 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-02-15$74.65/sh−1,381→ 71,709 total
Purchase
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2023-09-22$59.38/sh+4,000→ 73,090 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2023-06-09$73.76/sh−420→ 69,090 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2023-02-23+46,178→ 46,178 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2023-02-23+17,005→ 68,791 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2022-12-22+2,081→ 2,081 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2022-12-05+132,000→ 132,000 total
Award
Vaxart, Inc.$VXRT
Stock Option (right to buy)
2022-08-04+44,224→ 44,224 total
Award
Vaxart, Inc.$VXRT
Common Stock
2022-08-04+7,375→ 125,905 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2022-06-10+4,340→ 4,340 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2022-06-10+1,004→ 51,786 total
Disposition to Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (right to buy)
2022-03-22−85,760→ 0 total
Disposition to Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (right to buy)
2022-03-22−48,123→ 0 total
Disposition to Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units
2022-03-22−22,685→ 0 total
Other
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
2022-03-22−252,207→ 0 total
Award
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options (right to buy)
2022-01-27$3.66/sh+85,760→ 85,760 total
Exercise/Conversion
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units
2022-01-27−7,684→ 7,685 total

Companies

Recent Filings

Address

11085 NORTH TORREY PINES ROAD, SUITE 300

LA JOLLA, CA, 92037

View on SEC.gov